1-20 of 149
D Wagner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia

Clinical Trials & Observations
Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Carol Ann Huff, Tania Jain, Lode J. Swinnen, Philip H. Imus, Nina D. Wagner-Johnston, Richard F. Ambinder, Mark Levis, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky
Journal: Blood
Blood (2023) 141 (25): 3031–3038.
https://doi.org/10.1182/blood.2023020435
Published: 2023
Includes: Supplemental data
Journal Articles

Allogeneic Blood or Marrow Transplantation (AlloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) for Acute Lymphoblastic Leukemia (ALL) in Patients Aged ≥ 55: Best Results in B ALL in First Remission (CR1) with Reduced-Intensity Conditioning (RIC)

Jonathan Allen Webster, Madison C. Reed, Hua-Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern, Mark J. Levis, Margaret M. Showel, Gabrielle T. Prince, Christopher S. Hourigan, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Suman Paul, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Douglas E. Gladstone, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Ivana Gojo, B. Douglas Douglas Smith, Ravi Varadhan, Richard J. Jones, Philip H. Imus
Journal: Blood
Blood (2022) 140 (Supplement 1): 4813–4815.
https://doi.org/10.1182/blood-2022-171038
Published: 2022
Journal Articles

Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Jeffrey P. Ward, Melissa M. Berrien-Elliott, Felicia Gomez, Jingqin Luo, Michelle Becker-Hapak, Amanda F. Cashen, Nina D. Wagner-Johnston, Kami Maddocks, Matthew Mosior, Mark Foster, Kilannin Krysiak, Alina Schmidt, Zachary L. Skidmore, Sweta Desai, Marcus P. Watkins, Anne Fischer, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger, Nancy L. Bartlett
Journal: Blood
Blood (2022) 139 (13): 1999–2010.
https://doi.org/10.1182/blood.2021011894
Published: 2022
Includes: Supplemental data
Journal Articles

Nonmyeloablative Allogeneic Transplantation in First Remission for Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Outcomes By Receipt of Pre-Transplant Blinatumomab

Jonathan Webster, B. Douglas Smith, Amy E. DeZern, Alexander J. Ambinder, Mark Levis, Margaret M. Showel, Gabrielle T. Prince, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Christopher S. Hourigan, Tania Jain, Douglas E Gladstone, Leo Luznik, Philip H. Imus, Javier Bolanos-Meade, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Richard J. Jones, Ivana Gojo
Journal: Blood
Blood (2021) 138 (Supplement 1): 1846.
https://doi.org/10.1182/blood-2021-153750
Published: 2021
Journal Articles

Phase I Study of Oral Azacitidine (CC-486) Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Brian T. Hess, Leandro Cerchietti, Lindsey Hendrickson, Elizabeth Hill, Anshu Giri, Shanta Salzer, Sarah Hogan, Lacey Finch, Robin Klingenberg, Fang Hu, Nina D. Wagner-Johnston
Journal: Blood
Blood (2021) 138 (Supplement 1): 3567.
https://doi.org/10.1182/blood-2021-145493
Published: 2021
Journal Articles

Phase II Study of Venetoclax in Combination with Obinutuzumab and Bendamustine in Patients with High Tumor Burden Follicular Lymphoma As Front Line Therapy (PrECOG 0403)

Craig A. Portell, Opeyemi Jegede, Nina D. Wagner-Johnston, Grzegorz S. Nowakowski, Christopher D. Fletcher, Jonathon B. Cohen, Kevin A. David, Nadia Khan, Lori J Rosenstein, Brad S. Kahl
Journal: Blood
Blood (2021) 138 (Supplement 1): 814.
https://doi.org/10.1182/blood-2021-145217
Published: 2021
Journal Articles

Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Assessing the Importance of Conditioning Regimen, Donor Choice, and Tyrosine Kinase Inhibitor Use

Jonathan Webster, MD, Leo Luznik, MD, Hua-Ling Tsai, ScM, Philip H. Imus, MD, Amy E. DeZern, MD, Keith W. Pratz, MD, Mark Levis, MD PhD, Ivana Gojo, MD, Margaret M. Showel, MD, Gabrielle T. Prince, MD, Javier Bolanos-Meade, MD, Lukasz P. Gondek, MDPhD, Gabriel Ghiaur, MD PhD, William Brian Dalton, MD PhD, Tania Jain, MD, Ephraim J. Fuchs, MD MBA, Douglas E Gladstone, MD, Christian B. Gocke, MD PhD, Abbas Abbas Ali, MD, Carol Ann Huff, MD, Ivan M. Borrello, MD, Lode J. Swinnen, MB ChB, Nina D. Wagner-Johnston, Richard F. Ambinder, MD, Richard J. Jones, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-141294
Published: 2020
Journal Articles

Reduced-Intensity Induction with Dasatinib Vs. Hypercvad + 2 nd Generation TKIs with MRD-Guided Follow-up Therapy Leads to Comparable Rates of MRD-Negative Remission While Reducing Transfusions and Neutropenia in Ph+ ALL

Jonathan Webster, MD, Hua-Ling Tsai, ScM, Eric Gehrie, Tania Jain, MD, Christopher S. Hourigan, MDDPhil, William Brian Dalton, MD PhD, Gabrielle T. Prince, MD, Lukasz P. Gondek, MDPhD, Gabriel Ghiaur, MD PhD, Amy E. DeZern, MD, Margaret M. Showel, MD, Ivana Gojo, MD, Douglas E Gladstone, MD, Philip H. Imus, MD, Javier Bolanos-Meade, MD, Leo Luznik, MD, Ephraim J. Fuchs, MD MBA, Christian B. Gocke, MD PhD, Abbas Abbas Ali, MD, Carol Ann Huff, MD, Ivan M. Borrello, MD, Lode J. Swinnen, MB ChB, Nina D. Wagner-Johnston, Richard F. Ambinder, MD, Richard J. Jones, MD, B. Douglas Smith, MD, Mark Levis, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-141264
Published: 2020
Journal Articles

AVAIL-T: A Phase 2a Trial of Avelumab, and Anti-PD-L1 Antibody, in Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL)

Matthew J Ahearne, Charlotte Gaskell, BSc, MSc, Aimee E Jackson, BSc, MSc, Clare Morland, PhD, Louise Hopkins, Nadia Nawaz, Matthew A Timmins, Christopher P Fox, MD PhD, Graham P. Collins, MD DPhil, Andrew Davies, David John Lewis, MD, Kate Cwynarski, Kim Linton, MBChB, MRCP, PhD, Pam McKay, MD, Rod Johnson, Simon D. Wagner
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-136061
Published: 2020
Journal Articles

Outcomes of Patients with Limited-Stage Plasmablastic Lymphoma

Brian T. Hess, MD, Anshu Giri, MD, Yeonhee Park, PhD, Krina K. Patel, MD, Brian K. Link, MD, Grzegorz S. Nowakowski, MD, Seth M Maliske, MD, Sonia Fortin, Julio C. Chavez, MD, Hayder Saeed, MD, Brian T. Hill, MD, Alex V. Mejia Garcia, MD, Kami J. Maddocks, MD, Walter Hanel, MD, Nina D. Wagner-Johnston, Marcus Raymond Messmer, MD, Brad S. Kahl, MD, Marcus Watkins, PhD, Juan Pablo Alderuccio, MD, Izidore S. Lossos, MD, Sunita Nathan, MD, Victor M. Orellana-Noia, MD, Craig A. Portell, MD, Daniel J. Landsburg, MD, Emily C. Ayers, MD, Jorge J. Castillo, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-138536
Published: 2020
Journal Articles

Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel

Charalambos Andreadis, MD MSCE, Constantine S. Tam, MBBS, MD, Peter Borchmann, MD PhD, Ulrich Jaeger, MD, Joseph P. McGuirk, DO, Harald Holte, MD PhD, Edmund K. Waller, PhDMD, Samantha Jaglowski, MDMPH, Michael R. Bishop, MD, Stephen Ronan Foley, MD FRCPC, Jason R. Westin, MD, Isabelle Fleury, MD, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), Stephan Mielke, MD, Takanori Teshima, MD, Gilles A. Salles, MD PhD, Stephen J Schuster, MD, Veronika Bachanova, MD PhD, Richard T. Maziarz, MD, Koen Van Besien, MD PhD, Koji Izutsu, MD PhD, John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Paolo Corradini, Ranjan Tiwari, MSc, Rakesh Awasthi, PhD, Tomasz Lawniczek, MD, Lamis K. Eldjerou, MD, Marie Jose Kersten, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2883.
https://doi.org/10.1182/blood-2019-124492
Published: 2019
Journal Articles

Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)

Veronika Bachanova, MD PhD, Constantine S. Tam, MBBS, MD, Peter Borchmann, MD, Ulrich Jaeger, MD, Joseph P. McGuirk, DO, Harald Holte, MD PhD, Edmund K. Waller, PhDMD, Samantha Jaglowski, MDMPH, Michael R. Bishop, MD, Charalambos Andreadis, MD MSCE, Stephen Ronan Foley, MD FRCPC, Jason R. Westin, MD, Isabelle Fleury, MD, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), Stephan Mielke, MD, Takanori Teshima, MD, Gilles Salles, MD PhD, Stephen J Schuster, MD, Richard T. Maziarz, MD, Koen Van Besien, MD PhD, Koji Izutsu, MD PhD, Marie Jose Kersten, MD PhD, John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Paolo Corradini, Jufen Chu, PhD, Irina Gershgorin, PhD, Therese Choquette, PhD, Lida Bubuteishvili Pacaud, MD, Margit Jeschke, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 242.
https://doi.org/10.1182/blood-2019-128302
Published: 2019
Journal Articles

Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial

Jason R. Westin, MD, Constantine S. Tam, MBBS, MD, Peter Borchmann, MD, Ulrich Jaeger, MD, Joseph P. McGuirk, DO, Harald Holte, MD PhD, Edmund K. Waller, PhDMD, Samantha Jaglowski, MDMPH, Michael R. Bishop, MD, Charalambos Andreadis, MD MSCE, Stephen Ronan Foley, MD FRCPC, Isabelle Fleury, MD, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), Stephan Mielke, MD, Takanori Teshima, MD, Stephen J Schuster, MD, Veronika Bachanova, MD PhD, Richard T. Maziarz, MD, Koen Van Besien, MD PhD, Koji Izutsu, MD PhD, Marie Jose Kersten, MD PhD, John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Paolo Corradini, Xia Han, MS, Ranjan Tiwari, MSc, Sergei Agoulnik, PhD, Lamis K. Eldjerou, MD, Lida Bubuteishvili Pacaud, MD, Gilles A. Salles, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4103.
https://doi.org/10.1182/blood-2019-129107
Published: 2019
Journal Articles

Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia

Nina D. Wagner-Johnston, MD, Stephen J. Schuster, MD, Sven de Vos, MD PhD, Gilles A. Salles, MD PhD, Wojciech Jurczak, MD PhD, Nishan Rajakumaraswamy, MD, Guan Xing, PhD, Ajay K. Gopal, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4006.
https://doi.org/10.1182/blood-2019-121936
Published: 2019
Journal Articles

Safety and Anti-Tumor Activity Study of Loncastuximab Tesirine and Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma

Julien Depaus, Locke J. Bryan, MD, David Ungar, MD, Ilva Dautaj, Nina D. Wagner-Johnston, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5309.
https://doi.org/10.1182/blood-2019-126913
Published: 2019
Journal Articles

Impact of Idelalisib Treatment Interruption with or without Dose Reduction on Outcomes in Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Shuo Ma, MD PhD, Rebecca J Chan, MD PhD, Lin Gu, MS, Guan Xing, PhD, Nishan Rajakumaraswamy, MD, Bianca Ruzicka, PhD, Nina D. Wagner-Johnston, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5468.
https://doi.org/10.1182/blood-2019-124541
Published: 2019
Journal Articles

Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 Patients

Cole Sterling, MD, Nina D. Wagner-Johnston, MD, Douglas E Gladstone, MD, Richard F. Ambinder, MD, Lode J. Swinnen, MB ChB, Philip Hollingsworth Imus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3342.
https://doi.org/10.1182/blood-2019-126253
Published: 2019
Journal Articles

A Phase IB Study of Blinatumomab (blina) in Patients with B Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or Marrow Transplant (allo-BMT) Remission Maintenance

Jonathan Webster, MD, Richard F. Ambinder, MD, Richard J. Jones, MD, Nina D. Wagner-Johnston, MD, Gabrielle T. Prince, MD, Audra Shedeck, CRNP, Amanda Blackford, MS, Leo Luznik, MD, Ivana Gojo, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 778.
https://doi.org/10.1182/blood-2019-128255
Published: 2019
Journal Articles

Resolvin D4 attenuates the severity of pathological thrombosis in mice

Deya Cherpokova, Charlotte C. Jouvene, Stephania Libreros, Elise P. DeRoo, Long Chu, Xavier de la Rosa, Paul C. Norris, Denisa D. Wagner, Charles N. Serhan
Journal: Blood
Blood (2019) 134 (17): 1458–1468.
https://doi.org/10.1182/blood.2018886317
Published: 2019
Includes: Supplemental data
Journal Articles

Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy

Nicole A Carreau, MD, Orrin Pail, MD, Philippe Armand, MD PhD, Reid W Merryman, MD, Ranjana H Advani, MD, Michael A Spinner, MD, Alex F. Herrera, MD, Robert W. Chen, MD, Sarah Tomassetti, MD, Radhakrishnan Ramchandren, MD, Muhammad Hamid, MD, Sarit Assouline, Raoul Santiago, MD, Nina D. Wagner-Johnston, MD, Suman Paul, PhDMD, Jakub Svoboda, MD, Steven M. Bair, MD, Stefan Klaus Barta, MDMRCP,MS, Yang Liu, MD, Sunita Nathan, MD, Madelyn Burkart, MD, Reem Karmali, MD, Pallawi Torka, MD, Kevin A. David, MD, Catherine Wei, MD MA, Frederick Lansigan, MD, Lukas Emery, MD, Daniel Persky, MD, Sonali M. Smith, MD, Julio C. Chavez, MD, Yuhe Xia, MS, Andrea B Troxel, ScD, Catherine Diefenbach, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1626.
https://doi.org/10.1182/blood-2018-99-117672
Published: 2018